Related Experiment Video
Updated: Jul 17, 2025

06:44
Modeling Brain Metastases Through Intracranial Injection and Magnetic Resonance Imaging
Published on: June 7, 2020
7.4K
Modeling gamma knife radiosurgical toxicity for multiple brain metastases
Eric J Hsu1, Yulong Yan1, Robert D Timmerman1
1Department of Radiation Oncology, UT Southwestern Medical Center, Dallas, TX, USA.
Summary
Tumor surface area and a power-law model accurately predict 12 Gy normal brain volume (V12), minimizing radiosurgical toxicity for brain metastases. This approach aids in estimating radionecrosis risk and optimizing radiation doses without specialized software.
Area of Science:
- Radiation Oncology
- Neurosurgery
- Medical Physics
Background:
- Radiation oncology protocols for radiosurgery rely on predicting the risk of radionecrosis using the 12 Gy normal brain volume (V12).
- Accurate prediction of V12 is crucial for setting appropriate dosing criteria and minimizing treatment toxicity.
Purpose of the Study:
- To evaluate tumor surface area (SA) and a simple power-law model using pre-treatment variables for estimating and minimizing radiosurgical toxicity.
- To develop a predictive model for V12 that does not require specialized planning software.
Main Methods:
- Retrospective review of 245 patients with 1217 brain metastases treated with Gamma Knife radiosurgery.
- Univariate, multivariable linear regression, and power-law models were used to identify predictors of V12.
- A power-law model (V12 ~ Rxn^1.5 * LAD^2) was developed and validated on a separate cohort.
Main Results:
- Tumor surface area was the best univariate predictor of V12 (adjR^2 = 0.770).
- The power-law model explained 90% of the variance in V12 across 1217 lesions and 245 patients.
- The model demonstrated strong predictive capability in an independent validation cohort.
Conclusions:
- Tumor surface area is a highly accurate univariate predictor of V12 for metastatic brain lesions.
- A novel pre-treatment power-law model effectively estimates V12, aiding in radionecrosis risk assessment and dose prescription for brain metastases.
- This model facilitates safe dose escalation strategies without reliance on planning software.

